Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Roche Boosts Molecular Portfolio with Deals to Acquire GeneWEAVE, Kapa Biosystems
By Stephanie Murg, Managing Director, G2 Intelligence With some 60% of its therapeutic candidates now being co-developed with companion diagnostics, Roche (Basel, Switzerland) is investing in both its diagnostics business and its drug pipeline with two recently...
OPKO, Bio-Reference Complete Deal
By Ron Shinkman, Editor, Laboratory Industry Report Miami-based OPKO Health has completed its acquisition of New Jersey-based Bio-Reference Laboratories. Under the terms of the all-stock deal, Bio-Reference shareholders received 2.75 shares of OPKO stock in a deal...
Biocept, UC Irvine to Collaborate on Liquid Biopsies
By Ron Shinkman, Editor, Laboratory Industry Report San Diego-based Biocept will collaborate with the University of California at Irvine to study differences in biomarkers in blood-based specimens versus invasive tissue samples. The intent, officials say, is to be...
Drones Feasible for Lab Specimen Delivery
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Unmanned Aerial Systems (UAS or drones) could potentially be used to transport clinical laboratory specimens. Transportation of laboratory specimens via small UASs does not affect the accuracy of...